Thromb Haemost 2007; 98(04): 806-812
DOI: 10.1160/TH07-03-0207
Platelets and Blood Cells
Schattauer GmbH

PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets

Vandana S. Dole
1   CBR Institute for Biomedical Research, Harvard Medical School, Boston, Massachusetts, USA
2   Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
,
Wolfgang Bergmeier
1   CBR Institute for Biomedical Research, Harvard Medical School, Boston, Massachusetts, USA
2   Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
,
Ian S. Patten
1   CBR Institute for Biomedical Research, Harvard Medical School, Boston, Massachusetts, USA
,
Junichi Hirahashi
3   Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
,
Tanya N. Mayadas
3   Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
,
Denisa D. Wagner
1   CBR Institute for Biomedical Research, Harvard Medical School, Boston, Massachusetts, USA
2   Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
› Author Affiliations
Financial support: This work was supported by National Institutes of Health, National Heart, Lung, and Blood Institute grants R37 HL41002 and P01 HL066105 (D.D.W.) and P01 HL 036028 (T.N.M.); National Institute of Arthritis and Musculoskeletal and Skin Diseases grant AR050800–03 (T.N.M.); and American Heart Association Scientist Development Grant 0630044N (W.B.).
Further Information

Publication History

Received 19 March 2007

Accepted after resubmission 12 July 2007

Publication Date:
01 December 2017 (online)

Summary

We have previously shown that activated platelets in circulation stimulate release of endothelial Weibel-Palade bodies thus increasing leukocyte rolling in venules. P-selectin on the activated platelets mediates adhesion to leukocytes via PSGL-1 and is rapidly shed into plasma. We were interested in studying the role of PSGL-1 in regulating expression and function of platelet P-selectin. We show here that PSGL-1 is critical for the activation of endothelial cells in venules of mice infused with activated platelets. The interaction of platelet P-selectin with PSGL-1 is also required for P-selectin shedding, as P-selectin was retained significantly longer on the surface of activated platelets infused into PSGL-1-/- compared to wild-type mice. The leukocyte integrin αMβ2 (Mac-1) was not required for P-selectin shedding. In addition to shedding, P-selectin can be downregulated from the platelet surface through internalization and this is the predominant mechanism in the absence of PSGL-1. We demonstrate that leukocyte- neutrophil elastase,known to cleave P-selectin in vitro, is not the major sheddase for P-selectin in vivo. In conclusion, interaction of platelet P-selectin with PSGL-1 is crucial for activation of the endothelium andWeibel-Palade body secretion. The interaction with PSGL-1 also results in rapid shedding of P-selectin thus downregulating the inflammatory potential of the platelet.

 
  • References

  • 1 McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001; 86: 746-756.
  • 2 Andre P. P-selectin in haemostasis. Br J Haematol 2004; 126: 298-306.
  • 3 Frenette PS, Johnson RC, Hynes RO. et al. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995; 92: 7450-7454.
  • 4 Dole VS, Bergmeier W, Mitchell HA. et al. Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin. Blood 2005; 106: 2334-2339.
  • 5 Ludwig RJ, Schultz JE, Boehncke WH. et al. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 2004; 122: 830-836.
  • 6 Furman MI, Benoit SE, Barnard MR. et al. Increased platelet reactivity and circulating monocyteplatelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31: 352-358.
  • 7 Elizalde JI, Gomez J, Panes J. et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997; 100: 996-1005.
  • 8 Huo Y, Schober A, Forlow SB. et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 61-67.
  • 9 Evangelista V, Manarini S, Sideri R. et al. Platelet/ polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 1999; 93: 876-885.
  • 10 da Costa Martins PA, van Gils JM, Mol A. et al. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J Leukoc Biol 2006; 79: 499-507.
  • 11 Simon DI, Chen Z, Xu H. et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000; 192: 193-204.
  • 12 Weber C, Springer TA. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J Clin Invest 1997; 100: 2085-2093.
  • 13 Frenette PS, Moyna C, Hartwell DW. et al. Plate-letendothelial interactions in inflamed mesenteric venules. Blood 1998; 91: 1318-1324.
  • 14 Rivera-Nieves J, Burcin TL, Olson TS. et al. Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis. J Exp Med 2006; 203: 907-917.
  • 15 da Costa Martins P, Garcia-Vallejo JJ, van Thienen JV. et al. P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium. Arterioscler Thromb Vasc Biol 2007; 27: 1023-1029.
  • 16 Michelson AD, Barnard MR, Hechtman HB. et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877-11882.
  • 17 Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood 1998; 92: 4446-4452.
  • 18 Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003; 101: 2661-2666.
  • 19 Carter AM, Anagnostopoulou K, Mansfield MW. et al. Soluble P-selectin levels, P-selectin polymorphisms and cardiovascular disease. J Thromb Haemost 2003; 1: 1718-1723.
  • 20 Marschang P, Friedrich GJ, Ditlbacher H. et al. Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease. Int J Cardiol 2006; 106: 183-190.
  • 21 Woollard KJ, Kling D, Kulkarni S. et al. Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ Res 2006; 98: 149-156.
  • 22 Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001; 103: 491-495.
  • 23 Andre P, Hartwell D, Hrachovinova I. et al. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000; 97: 13835-13840.
  • 24 Hrachovinova I, Cambien B, Hafezi-Moghadam A. et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003; 9: 1020-1025.
  • 25 Falati S, Liu Q, Gross P. et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-1598.
  • 26 Cambien B, Wagner DD. A new role in hemostasis for the adhesion receptor P-selectin. Trends Mol Med 2004; 10: 179-186.
  • 27 Gardiner EE, De Luca M, McNally T. et al. Regulation of P-selectin binding to the neutrophil P-selectin counter-receptor P-selectin glycoprotein ligand-1 by neutrophil elastase and cathepsin G. Blood 2001; 98: 1440-1447.
  • 28 Mayadas TN, Johnson RC, Rayburn H. et al. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993; 74: 541-554.
  • 29 Ley K. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 2002; 186: 8-18.
  • 30 Coxon A, Rieu P, Barkalow FJ. et al. A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 1996; 5: 653-666.
  • 31 Belaaouaj A, McCarthy R, Baumann M. et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998; 4: 615-618.
  • 32 Frenette PS, Denis CV, Weiss L. et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000; 191: 1413-1422.
  • 33 James HL, Wachtfogel YT, James PL. et al. A unique elastase in human blood platelets. J Clin Invest 1985; 76: 2330-2337.
  • 34 Millan J, Ridley AJ. Rho GTPases and leucocyteinduced endothelial remodelling. Biochem J 2005; 385: 329-337.
  • 35 Ma YQ, Plow EF, Geng JG. P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. Blood 2004; 104: 2549-2556.
  • 36 Nieswandt B, Bergmeier W, Rackebrandt K. et al. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood 2000; 96: 2520-2527.
  • 37 Schulte V, Rabie T, Prostredna M. et al. Targeting of the collagen-binding site on glycoprotein VI is not essential for in vivo depletion of the receptor. Blood 2003; 101: 3948-3952.
  • 38 Kawabata K, Hagio T, Matsuoka S. The role of neutrophil elastase in acute lung injury. Eur J Pharmacol 2002; 451: 1-10.
  • 39 Massberg S, Brand K, Gruner S. et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002; 196: 887-896.
  • 40 Bergmeier W, Piffath CL, Cheng G. et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res 2004; 95: 677-683.
  • 41 Bergmeier W, Rabie T, Strehl A. et al. GPVI downregulation in murine platelets through metalloproteinase- dependent shedding. Thromb Haemost 2004; 91: 951-958.
  • 42 Michelson AD, Benoit SE, Furman MI. et al. The platelet surface expression of glycoprotein V is regulated by two independent mechanisms: proteolysis and a reversible cytoskeletal-mediated redistribution to the surface-connected canalicular system. Blood 1996; 87: 1396-1408.
  • 43 Rabie T, Strehl A, Ludwig A. et al. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 2005; 280: 14462-14468.
  • 44 Subramaniam M, Koedam JA, Wagner DD. Divergent fates of P- and E-selectins after their expression on the plasma membrane. Mol Biol Cell 1993; 4: 791-801.
  • 45 Bodary PF, Homeister JW, Vargas FB. et al. Generation of soluble P- and E-selectins in vivo is dependent on expression of P-selectin glycoprotein ligand-1. J Thromb Haemost 2007; 5: 599-603.